Combining AI and traditional screening for discovery of a potent ROCK2 inhibitor against lymphoma
Yan Lu(Second Affiliated Hospital of Zhejiang University), Xinglong Chi(State Key Laboratory of Natural Medicine), Zheyuan Shen(Second Affiliated Hospital of Zhejiang University), Donghang Xu(Zhejiang Lab), Lei Xu(China Pharmaceutical University), Jingyi Zhao(Zhejiang University), Shuangshuang Geng(Zhejiang University), Tianshu Zhang(Second Affiliated Hospital of Zhejiang University), Jiaxun Ying(Hangzhou Medical College), Qingnan Zhang(Zhejiang Lab), Jian Gao(Zhejiang University), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University), Liteng Shen(Zhejiang Lab)
Cited by 1
Related Papers
ADCdb: the database of antibody–drug conjugates
|Nucleic Acids Research|2023|69
Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation
|Journal of Advanced Research|2021|45
Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors
|Frontiers in Pharmacology|2020|44
TransFoxMol: predicting molecular property with focused attention
|Briefings in Bioinformatics|2023|40
Can molecular dynamics simulations improve predictions of protein-ligand binding affinity with machine learning?
|Briefings in Bioinformatics|2023|37